Feasibility, safety and effectiveness of robot-assisted retroperitoneal partial adrenalectomy with a new robotic surgical system: A prospective clinical study

Abstract

ObjectivesTo evaluate the feasibility, safety and efficacy of the newly developed KD-SR-01® robotic system for retroperitoneal partial adrenalectomy.Subjects and MethodsWe prospectively enrolled patients with benign adrenal mass undergoing KD-SR-01® robot-assisted partial adrenalectomy in our institution from November 2020 to May 2022. Surgeries were performed via a retroperitoneal approach using the KD-SR-01® robotic system. The baseline, perioperative and short-term follow-up data were prospectively collected. A descriptive statistical analysis was performed.ResultsA total of 23 patients were enrolled, including nine (39.1%) patients with hormone-active tumors. All patients received partial adrenalectomy via the retroperitoneal approach without conversions to other procedures. The median operative time was 86.5 min [interquartile range (IQR), 60.0–112.5] and the median estimated blood loss was 50 ml (range, 20–400). Three (13.0%) patients developed Clavien-Dindo grade I-II postoperative complications. The median postoperative stay was 4.0 days (IQR, 3.0–5.0). All surgical margins were negative. The short-term follow-up demonstrated complete or partial clinical and biochemical success as well as absence of imaging recurrence in all patients with hormone-active tumors.ConclusionsInitial results illustrate that the KD-SR-01® robotic system is safe, feasible and effective for the surgical management of benign adrenal tumors.

Evaluation of Clinical Research on Novel Multiport Robotic Platforms for Urological Surgery According to the IDEAL Framework: A Systematic Review of the Literature

“…The remaining 59 studies included in our systematic review were noncomparative surgical series or case reports [30] , [31] , [32] , [33] , [34] , [35] , [36] , [37] , [38] , [39] , [40] , [41] , [42] , [43] , [44] , [45] , [46] , [47] , [48] , [49] , [50] , [51] , [52] , [53] , [54] , [55] , [56] , [57] , [58] , [59] , [60] , [61] , [62] , [63] , [64] , [65] , [66] , [67] , [68] , [69] , [70] , [71] , [72] , [73] , [74] , [75] , [76] , [77] , [78] , [79] , [80] , [81] , [82] , [83] , [84] , [85] , [86] , [87] , [88] .…”

“…Eleven studies reporting clinical data on the KangDuo robot were included in our review [15] , [26] , [27] , [58] , [59] , [60] , [61] , [62] , [63] , [64] , [65] ( Table 4 ). The first clinical procedure with the KangDuo surgical robot was performed in China in 2021.…”

Evaluation status of current and emerging minimally invasive robotic surgical platforms

“…Stage 2b: Prospective single arm studies for RARP [ 38 ], partial adrenalectomy [ 39 ], pyeloplasty comparing to da Vinci Si, da Vinci outperformed in operative time and time per stitch [ 40 ]…”

Evaluation of a Newly-developed Oral and Maxillofacial Surgical Robotic Platform (KD-SR-01) in Head and Neck Surgery: A Preclinical Trial in Porcine Models

“…Secondly, the KD-SR's arm con guration also differs. It features grouped arms mounted on a rotatable boom, facilitating easier patient positioning adjustments compared to da Vinci's independent arms 25 . Anticipated future advancements for the this newly-developed surgical robotic system includes enhanced imaging with uorescence, fully independent arm movements, real-time haptic feedback, and the development of single-port arms.…”

“…This system has demonstrated promising outcomes in urology. [24][25][26] However, its feasibility, effectiveness, and safety in head and neck surgery are yet to be extensively investigated. This study aims to conduct a pioneering preclinical investigation into the viability and potential of the newly-developed robotic surgical platform in the eld of head and neck surgery.…”